GMI in the News

Here, we provide links to recent news coverage for GlycoMimetics and our scientific programs.

December 11, 2013

Study examines new class of anticoagulants for VTE prevention and treatment

June 5, 2013

GlycoMimetics CEO Rachel King named Maryland Life Sciences Advisory Board Chair

April 28, 2013

The Download: Rachel King named chairwoman of Biotechnology Industry Organization board

April 23, 2013

BIO elects GlycoMimetics' Rachel King as new chair

January 21, 2013

GlycoMimetics completes enrolment in GMI-1070 Phase II sickle cell disease study

July 6, 2012

Pfizer Chief Medical Officer Freda Lewis-Hall, M.D., Highlights Pfizer/GlycoMimetics Partnership in Blog Post on Essence Music Festival Panel: "The 2012 Black Women's Agenda: The High Cost of Living in America"

March 16, 2012

Thackray helps spearhead GlycoMimetics’ therapeutic efforts

February 1, 2012

Female Frontrunners: How to successfully surmount the challenges women face in becoming biotech industry leaders

January 1, 2012

Pfizer Q4 Results with GlycoMimetics Mention

October 11, 2011

Pfizer inks $340M rare disease pact with GlycoMimetics

August 9, 2011

Hope for Sickle Cell Patients...GlycoMimetics Paving the Way

January 20, 2011

Two edges of sickle cell disease

December 1, 2010

Top 10 Women in Biotech (featuring Rachel King)

March 26, 2009

GlycoMimetics completes drug trial

September 8, 2008

GlycoMimetics’ sickle cell drug enters human tests